News: Brokerage

Rudin welcomes Hamptons BioMed to 211 East 70th

Manhattan, NY Hamptons BioMedsigned a new retail lease, which will open its first Biomedical Longevity Clinic in the city on the ground floor of 211 East 70th St.

Rudin was represented in-house by Kevin Daly along with Josef Yadgarov from Wexler Healthcare & Commercial Properties of The Corcoran Group.

Founded in Southampton and led by medical expert Dr. Jeffrey Morrison, clinical nutritionist Tapp Francke and longevity technology specialist Jess Arden, Hamptons BioMed blends integrative medical services, cutting-edge longevity technologies, and holistic therapies to support long-term wellness. As part of a 10-year deal, Hamptons BioMed will occupy 2,276 s/f.

“We are pleased to bring Hamptons BioMed to Manhattan and to join the community at 211 East 70th St.,” said Dr. Morrison. “Our team brings more than 25 years of experience in integrative and functional medicine with science-informed wellness and longevity technologies sourced globally. We look forward to serving the Manhattan community and empowering individuals to take a proactive, informed approach to optimizing their health and long-term well-being.”

Hamptons BioMed’s Upper East Side clinic will provide a comprehensive, client-centered approach to wellness, incorporating advanced IV therapies, peptides, nutritional guidance, and non-invasive longevity technologies such as the Human Regenerator Bed and ARRC Elysium Bed to support the body’s natural recovery, balance and performance processes. The clinic will offer personalized support and individualized programs to support detoxification pathways, promote balanced inflammatory and immune responses, and enhance overall vitality and resilience.

“Hamptons BioMed is an ideal addition to 211 East 70th St. and the Upper East Side,” said Kevin Daly, vice president of office leasing at Rudin. “Our residents and visitors from across the region stand to benefit from this cutting-edge clinic and renowned team that offers meaningful value by supporting healthier lifestyles and long-term well-being.”

Built by the Rudin family in 1976, 211 East 70th St. is one of the Upper East Side’s premier addresses. The building was enhanced in 2019 with a new facade and reimagined outdoor spaces by Skidmore, Owings & Merrill. The property offers apartments with select units showcasing views of Central Park, the East River, and Midtown. Residents enjoy exclusive amenities, including a through-block porte cochère and two landscaped gardens.

READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
New York’s streets are full again, and the retail numbers prove it - by Noam Aziz

New York’s streets are full again, and the retail numbers prove it - by Noam Aziz

Walk down any New York block this year and you can feel it. The sidewalks are crowded, the storefronts are lit, and the energy that defines this city is back at full volume.
The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

There was a time when an offering memorandum (OM) was pretty bare bones, some photos, a few bullet points on income, and a rent roll thrown in at the back. That used to get the job done. Not anymore. In 2025, buyers are sharper, faster, and more selective. They’re looking
Artificial intelligence in lending - by Lindsay Mesh Lotito

Artificial intelligence in lending - by Lindsay Mesh Lotito

Artificial intelligence (AI) is beginning to help transform lending by enhancing decision-making, improving risk management and streamlining operations. With AI-powered tools that analyze vast amounts of data, lenders are able to assess borrower creditworthiness more accurately and efficiently. AI can evaluate a wide range of factors,
Hunt commercial real estate question and answer: The total cost of relocation - by David Hunt

Hunt commercial real estate question and answer: The total cost of relocation - by David Hunt

You have a right to be concerned. I am always surprised at the companies that will negotiate the price of their new facility down to the last dollar, without thoroughly analyzing their